adenocarcinoma

(redirected from Adenocarcinomas)
Also found in: Thesaurus, Medical, Encyclopedia.

ad·e·no·car·ci·no·ma

 (ăd′n-ō-kär′sə-nō′mə)
n.
A malignant tumor originating in glandular tissue.

ad′e·no·car′ci·nom′a·tous (-nŏm′ə-təs, -nō′mə-təs) adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

adenocarcinoma

(ˌædɪnəʊˌkɑːsɪˈnəʊmə)
n, pl -mas or -mata (-mətə)
1. (Pathology) a malignant tumour originating in glandular tissue
2. (Pathology) a malignant tumour with a glandlike structure
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

ad•e•no•car•ci•no•ma

(ˌæd n oʊˌkɑr səˈnoʊ mə)

n., pl. -mas, -ma•ta (-mə tə)
1. a malignant tumor arising from secretory epithelium.
2. a malignant tumor of glandlike structure.
[1885–90]
ad`e•no•car`ci•nom′a•tous (-ˈnɒm ə təs, -ˈnoʊ mə-) adj.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.adenocarcinoma - malignant tumor originating in glandular epitheliumadenocarcinoma - malignant tumor originating in glandular epithelium
carcinoma - any malignant tumor derived from epithelial tissue; one of the four major types of cancer
prostate cancer, prostatic adenocarcinoma - cancer of the prostate gland
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

ad·e·no·car·ci·no·ma

n. adenocarcinoma, cáncer maligno que se origina en una glándula.
English-Spanish Medical Dictionary © Farlex 2012

adenocarcinoma

n adenocarcinoma m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
(7.) Kerr KM: Pulmonary adenocarcinomas: classification and reporting.
Awareness of the existence of papillary thyroid carcinoma like pulmonary adenocarcinoma will avoid misdiagnosis or unnecessary clinical and radiological investigations.
The study focused on the role of two cell signaling pathways--KEAP1/ NRF2 and PI3K-which are known to be involved in adenocarcinomas.
"More than one in five lung adenocarcinomas have alterations in the KEAP1/NRF2 pathway, suggesting it is a major cancer driver," Sutherland says.
Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using geneexpression profiles.
Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002;1:304-13.
Histologically, urachal adenocarcinomas (which are the most common carcinomas of urachal origin) overlap with their main differential diagnostic entities, that is, primary bladder adenocarcinomas and colorectal adenocarcinomas.
A total of 2154 cases of UrC were identified, with information on UrC histology available in 1984 cases (92%), of which 1834 (92%) were adenocarcinomas. The majority of studies with information on UrC cases were case reports (74%), while contributing only a minor part to the total number of cases (16%).
Just like in Her2/neu positive breast cancer, Trastuzumab (Herceptin) is also effective in Her2-positive gastric adenocarcinoma and is approved, in combination with chemotherapy, in the international phase III Trastuzumab for Gastric Cancer (ToGA) trial.5 It can be continued as monotherapy in patients with chemotherapeutic adverse reactions.3 The frequency of HER2-positive gastric cancer varies from 6% to 29.5%.3 The status of HER2/neu expression can be evaluated both on endoscopic biopsies or resection specimens using immunohistochemistory (IHC) or fluorescence in situ hybridisation (FISH).3 The current study was planned to determine HER/neu overexpression in gastric adenocarcinomas using IHC in a tertiary care setup.
According to the most recent WHO (World Health Organization) Classification of Tumors of Female Reproductive Organs published in 2014, endocervical adenocarcinomas are classified from descriptive morphologic characteristics, primarily cytoplasmic features.
Bladder adenocarcinoma may be primary or secondary; secondary adenocarcinomas are more common than primary adenocarcinomas in the bladder.
By contrast, adenocarcinomas account for up to 95% of all gastric cancers and are by far the most studied tumors [7].